# A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

> **NCT00139672** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 330 (—)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** PD-217,014

## Key facts

- **NCT ID:** NCT00139672
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 330 (—)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139672, "A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00139672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*